Clinical efficacy of buprenorphine: comparisons to methadone and placebo.

Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Abstract Text:

Walter Ling,Donald R Wesson,

Buprenorphine has been studied extensively since 1978 when it was initially proposed as an alternative to methadone for treatment of opioid dependence. Early work by and their colleagues demonstrated buprenorphine's low physical abuse potential and its ability to substitute for heroin and reduce heroin self-administration in opiate-dependent humans. The subsequent early clinical studies suggested that, in clinical settings, buprenorphine was a safe and efficacious opiate dependence pharmacotherapy. Formal approval for general clinical use, however, required that systematic data be gathered on buprenorphine's safety and efficacy in larger groups and a series of controlled clinical trials was designed to evaluate its utility from a medication development perspective. In general, these trials adhered to one of three basic protocol designs: comparison of buprenorphine to methadone; dose comparisons using dose response as an indicator of efficacy; and comparison of buprenorphine to placebo. Retention in treatment, reduction in illicit drug use and craving, and patient and staff ratings of improvements were the most frequently used outcome indicators in these trials. Additional data collected included optimum dosing and dosage schedules, adverse reactions and common side-effects, and other information intended to clarify buprenorphine's benefit-risk relationship and to help prepare guidelines for its safe marketing and utilization by physicians in general clinical practice. This paper presents a review of the buprenorphine/methadone comparison trials conducted in the United States and two such trials conducted in Europe. Also reviewed are three placebo-controlled trials and a buprenorphine/methadone detoxification study. Overall, this series of studies did firmly establish the efficacy of buprenorphine alone and in comparison to methadone.

Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Publishing Authors By Initials

W Ling,DR Wesson,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Drug and alcohol dependence

VOLUME: 70

Page Numbers: S49-57

Journal Abbreviation:

ISSN: 0376-8716

DAY: 21

MONTH: May

YEAR: 2003

Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7513587

Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Clinical efficacy of buprenorphine: comparisons to methadone and placebo. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical efficacy of buprenorphine: comparisons to methadone and placebo.

AFFILIATION: Integrated Substance Abuse Programs, Department of Psychiatry and Biobehavioral Sciences, School of Medicine, University of California Los Angles, 11075 Santa Monica Boulevard, Suite 200, 90025, Los Angeles, CA, USA

Country: Ireland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Drug Alcohol Depend

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical efficacy of buprenorphine: comparisons to methadone and placebo Related Publications

• A study of bladder function following vaginal hysterectomy.
• AN ANATOMICAL AND EMBRYOLOGICAL STUDY OF THE PERINEUM.
• Acidic polyanion poly(acrylic acid) prevents calcium oxalate crystal deposition.
• Adhesion between molecules and calcium oxalate crystals: critical interactions in kidney stone formation.
• BACKACHE DUE TO SEMINAL VESICULITIS AND PROSTATITIS.
• Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.
• CYSTS OF THE PROSTATE AND URETHRA.
• Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
• Concerning a Morphine Addict.
• Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors.
• Evaluation of diabetes primary care and effects on health care charges in elderly patients with diabeties.
• Fatal and non-fatal childhood injuries in Metropolitan Toronto, 1986-1991.
• Hydrops of the gall bladder in a fourteen-month-old infant.
• INDUSTRIAL HERNIA VERSUS SEMINAL VESICULITIS AND VASITIS.
• Increase in west nile neuroinvasive disease after hurricane katrina.
• Infections of the Genito-Urinary Tract.
• Is the ethnic disparity in CKD a symptom of dysfunctional primary care in the US?
• PYELOGRAPHY: COMMON DIAGNOSTIC ERRORS.
• PYELOGRAPHY: ERRORS IN TECHNIQUE AND INTERPRETATION.
• Rupture of Ureter-A Medico-Legal Problem: Report of Cases.
• Solitary nodule on the foot of a 37-year-old man. Atypical fibroxanthoma (AFX).
• Suggestions on therapeutic urology.
• THE IMPORTANCE OF BUCK'S AND COLLES' FASCIAE IN URINARY EXTRAVASATION.
• THE PROSTATIC MEDIAN BAR, COMPLICATIONS AND TREATMENT.
• THE VALUE OF TESTOSTERONE TO MEN PAST MIDDLE AGE.
• THE X-RAY AND CONSERVATIVE SURGERY IN THE TREATMENT OF MALIGNANT TUMORS OF THE TESTICLE AND SCROTOM.
• TRAUMATIC HYDROCELE: WITH AN ANALYSIS OF THIRTY CASES.
• The effect of tartronic acid on abnormal fat formation from carbohydrate.
• Urinary Calculi: Cause and Treatment.